• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞入侵的阻断:抗网织红细胞结合蛋白同源物5抗体的新评估

Blockade of erythrocyte invasion: New assessment of anti- reticulocyte-binding protein homolog 5 antibodies.

作者信息

Shen Yan, Wang Jun, Liu Xuewu, Liang Jiao, Huang Yuxiao, Liu Zhongxiang, Zhao Y A, Li Yinghui

机构信息

Department of Medical Microbiology and Parasitology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.

出版信息

Exp Ther Med. 2015 Apr;9(4):1357-1362. doi: 10.3892/etm.2015.2237. Epub 2015 Jan 29.

DOI:10.3892/etm.2015.2237
PMID:25780435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4353742/
Abstract

There is great interest in any new discoveries in malaria vaccine research. reticulocyte-binding protein homolog 5 (PfRH5) shows promise in this area and may be used together with other merozoite antigens as a potential vaccine. In the present study, a bioinformatics prediction approach was applied to a PfRH5 B-cell epitope, and two B-cell epitope distributions were selected. Antibodies against the two PfRH5 distributions were obtained and the growth activity inhibition was measured. No inhibition of the CY strain was found, but the growth of the 3D7 strain was inhibited by all of the antibodies, in contrast to the results of other studies. It was additionally found that certain quantities of protein led to the inhibition of the parasitic invasion. Equally noteworthy was that the survival time of the group immunized with a portion of PfRH5 was significantly longer than that of the group immunized with the full-length protein, following infection by ANKA. The present study produced conflicting results in and experiments, although the accuracy of the evaluation may be lessened due to the use of a murine malaria model. The findings of the present study may indicate that PfRH5 may not be suitable in malaria vaccine research.

摘要

疟疾疫苗研究中的任何新发现都备受关注。网织红细胞结合蛋白同源物5(PfRH5)在该领域显示出前景,可能与其他裂殖子抗原一起用作潜在疫苗。在本研究中,将生物信息学预测方法应用于PfRH5 B细胞表位,并选择了两种B细胞表位分布。获得了针对这两种PfRH5分布的抗体,并测量了生长活性抑制情况。未发现对CY株有抑制作用,但与其他研究结果相反,所有抗体均抑制了3D7株的生长。还发现一定量的蛋白质导致寄生虫入侵受到抑制。同样值得注意的是,在用ANKA感染后,用部分PfRH5免疫的组的存活时间明显长于用全长蛋白质免疫的组。尽管由于使用小鼠疟疾模型可能会降低评估的准确性,但本研究在实验中产生了相互矛盾的结果。本研究结果可能表明PfRH5可能不适用于疟疾疫苗研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/fbafb8f33fed/ETM-09-04-1357-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/dae6f868c389/ETM-09-04-1357-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/b64277c1d452/ETM-09-04-1357-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/fb2d2f026e0e/ETM-09-04-1357-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/fbafb8f33fed/ETM-09-04-1357-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/dae6f868c389/ETM-09-04-1357-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/b64277c1d452/ETM-09-04-1357-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/fb2d2f026e0e/ETM-09-04-1357-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4353742/fbafb8f33fed/ETM-09-04-1357-g03.jpg

相似文献

1
Blockade of erythrocyte invasion: New assessment of anti- reticulocyte-binding protein homolog 5 antibodies.红细胞入侵的阻断:抗网织红细胞结合蛋白同源物5抗体的新评估
Exp Ther Med. 2015 Apr;9(4):1357-1362. doi: 10.3892/etm.2015.2237. Epub 2015 Jan 29.
2
Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.尼日利亚拉各斯人群疟原虫红细胞结合蛋白同源物 5 候选疫苗中的遗传多态性。
Malar J. 2020 Jan 6;19(1):6. doi: 10.1186/s12936-019-3096-0.
3
Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.糖基磷脂酰肌醇(GPI)锚定的CyRPA与PfRH5和PfRipr之间的多蛋白复合物对于恶性疟原虫红细胞入侵至关重要。
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1179-84. doi: 10.1073/pnas.1415466112. Epub 2015 Jan 12.
4
Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria.恶性疟原虫网织红细胞结合蛋白同源物5抗体与临床疟疾防护的关联
Front Microbiol. 2014 Jun 30;5:314. doi: 10.3389/fmicb.2014.00314. eCollection 2014.
5
Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.恶性疟原虫网织红细胞结合蛋白同源物5相互作用蛋白PfRipr的鉴定,作为一种高度保守的血液期疟疾疫苗候选物。
Vaccine. 2016 Nov 4;34(46):5612-5622. doi: 10.1016/j.vaccine.2016.09.028. Epub 2016 Sep 28.
6
Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Reticulocyte-Binding Protein Homologue-5 in Kalifabougou, Mali.在马里加利法布古,疟疾候选疫苗原虫结合蛋白同源物-5 的多态性的范围和动态。
Am J Trop Med Hyg. 2018 Jul;99(1):43-50. doi: 10.4269/ajtmh.17-0737. Epub 2018 May 24.
7
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.人源抗疟原虫 PfRH5 和 PfCyRPA 抗体的双重作用:阻断入侵和使外质子虫无效化。
PLoS Pathog. 2023 Sep 15;19(9):e1011182. doi: 10.1371/journal.ppat.1011182. eCollection 2023 Sep.
8
PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor.PfRH5:恶性疟原虫一种与红细胞结合的新型网织红细胞结合家族同源物及其受体研究
PLoS One. 2008 Oct 1;3(10):e3300. doi: 10.1371/journal.pone.0003300.
9
Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.针对恶性疟原虫烯醇化酶的抗体实现对疟原虫的跨株中和。
Malar J. 2018 Aug 20;17(1):304. doi: 10.1186/s12936-018-2455-6.
10
Limited genetic variations of the Rh5-CyRPA-Ripr invasion complex in parasite population in selected malaria-endemic regions, Kenya.肯尼亚部分疟疾流行地区寄生虫种群中Rh5-CyRPA-Ripr入侵复合体的有限基因变异
Front Trop Dis. 2023 Mar 1;4:1102265. doi: 10.3389/fitd.2023.1102265.

本文引用的文献

1
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.全长重组恶性疟原虫 PfRH5 蛋白诱导具有抑制活性的抗体,可有效针对常见 PfRH5 遗传变异体。
Vaccine. 2013 Jan 2;31(2):373-9. doi: 10.1016/j.vaccine.2012.10.106. Epub 2012 Nov 10.
2
Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.增强对恶性疟原虫红细胞入侵的阻断作用:评估 PfRH5 抗体与其他裂殖子抗原抗体联合应用的效果。
PLoS Pathog. 2012;8(11):e1002991. doi: 10.1371/journal.ppat.1002991. Epub 2012 Nov 8.
3
Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms.
来自南美洲的恶性疟原虫野外分离株使用一种与入侵配体多态性相关的非典型红细胞入侵途径。
PLoS One. 2012;7(10):e47913. doi: 10.1371/journal.pone.0047913. Epub 2012 Oct 31.
4
Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.秘鲁洛雷托低疟疾传播地区抗恶性疟原虫入侵配体抗体。
Malar J. 2012 Oct 30;11:361. doi: 10.1186/1475-2875-11-361.
5
Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites.Basigin:一种多功能膜蛋白,在疟原虫感染中具有新的作用。
Expert Opin Ther Targets. 2012 Oct;16(10):999-1011. doi: 10.1517/14728222.2012.711818. Epub 2012 Aug 11.
6
Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition.基于 Mitotracker Red CMXRos 对活体无性血期疟原虫染色的流式细胞仪读数可靠地评估了抗体依赖性细胞抑制作用。
Malar J. 2012 Jul 20;11:235. doi: 10.1186/1475-2875-11-235.
7
Identifying an essential interaction between malaria parasites and erythrocytes unlocks the door to promising vaccine targets.确定疟原虫与红细胞之间的关键相互作用为有前景的疫苗靶点打开了大门。
Pathog Glob Health. 2012 Mar;106(1):64. doi: 10.1179/204777312X13305103762583.
8
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.疟原虫血期抗原 PfRH5 易受疫苗诱导的交叉株中和抗体的影响。
Nat Commun. 2011 Dec 20;2:601. doi: 10.1038/ncomms1615.
9
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum.Basigin 是恶性疟原虫入侵红细胞所必需的受体。
Nature. 2011 Nov 9;480(7378):534-7. doi: 10.1038/nature10606.
10
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.RTS,S/AS01 疟疾疫苗在非洲儿童中进行的 3 期临床试验的初步结果。
N Engl J Med. 2011 Nov 17;365(20):1863-75. doi: 10.1056/NEJMoa1102287. Epub 2011 Oct 18.